|Title:||Why the public should have a say in high-cost drug subsidies|
|Keywords:||high priced drugs|
|Abstract:||Decisions about public subsidies for high-cost drugs are naturally quite complex. And while patients have increasingly been given a voice in the process, the views of the wider community have generally not been sought. But given the rising cost of new drugs, perhaps it’s time to widen the discussion and start a debate about equity and the affordability of medicines.|
|Type of Work:||Article, Letter|
|Type of Publication:||Publisher version|
|Appears in Collections:||Research Papers and Publications. Public Health|
|Why the public should have a say in high-cost drug subsidies.pdf||534.63 kB||Adobe PDF|
Items in Sydney eScholarship Repository are protected by copyright, with all rights reserved, unless otherwise indicated.